Evidence map›Paper›PMID 41120716›Full record

ArticleBone marrow transplantation2026

Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT.

Patrizia Chiusolo, Michele Malagola, Fabio Giglio, Filippo Frioni, Carolina Secreto, Federica Lessi, Fabio D'Amore, Irene Maria Monella, Mariachiara Abbenante, Giovanni Marconi and 7 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Patrizia Chiusolo *Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-1355-1587
Michele MalagolaUniversity of Brescia, Adult Bone Marrow Transplant Unit, ASST Spedali Civili di Brescia, Brescia, Italy.ORCID http://orcid.org/0000-0003-0907-130X
Fabio GiglioIEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.
Filippo Frioni *Section of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Carolina SecretoDivision of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.
Federica LessiEmatologia Azienda Ospedale Padova, Padova, Italy.
Fabio D'AmoreEmatologia Azienda Ospedale Padova, Padova, Italy.
Irene Maria MonellaIEO, Clinical Haemato-Oncology Division Via Ripamonti, Milano, Italy.
Mariachiara AbbenanteOspedale Opera Padre Pio-San Giovanni Rotondo, San Giovanni Rotondo, Italy.
Giovanni MarconiDipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0001-6309-0515
Jacopo NanniIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Roberto MaggiSection of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Andrea MattozziSection of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Sabrina GiammarcoSection of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-1382-5496
Alessandro BuscaDivision of Haematology, Department of Oncology, A.O.U. Città Della Salute e della Scienza di Torino, Turin, Italy.ORCID http://orcid.org/0000-0001-5361-5613
Simona SicaSection of Hematology, Department of Laboratory and Hematological Sciences, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. simona.sica@unicatt.it.ORCID http://orcid.org/0000-0003-2426-3465
Cristina PapayannidisIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41120716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.